Search Results - "Moiseenko, F V"

CELLULAR IMMUNE REACTION IN A GREAT OMENTUM WITH METASTASES IN PATIENTS WITH OVARIAN CANCER by Khalikova, L. V., Moiseenko, F. V.

“…Introduction . Ovarian cancer is characterized by complex diagnostics and flow forecasting, which makes it important to search for prognostic criteria…”
Get full text

Assessment of the effectiveness of surgical resections following tyrosine kinase inhibitor therapy in patients with EGFR-mutated stage III–IV lung adenocarcinoma by Levchenko, E. V., Moiseenko, F. V., Orlov, S. V., Imyanitov, E. N., Mikhnin, A. E., Gelfond, M. L., Slugin, E. N., Ergnyan, S. M., Levchenko, N. E., Zhabina, A. S., Ulitin, A. M., Mamontov, O. Yu, Lopushanskaya, O. O., Artemeva, E. V., Murtazin, A. I., Shabinskaya, V. I.

“…Objective. To assess the overall and disease-free survival rates in patients with EGFR-mutated lung adenocarcinoma, who underwent surgery after achieving the…”
Get full text

Bladder cancer. A retrospective analysis of the use of vinfluvin in real clinical practice by A. S. Zhabina, A. I. Novikov, F. V. Moiseenko, N. M. Volkov, E. O. Stepanova, E. V. Artemeva, N. H. Abduloeva, V. M. Moiseenko

“…Purpose of the study. There is the generalized analysis of administration of vinflunine in real clinical practice in St.Petersburg Clinical Scientific and…”
Get full text

Efficacy of Videoendoscopic Inguinal Femoral Lymphadenectomy for Management of Metastatic Skin Melanoma by Egorenkov, V. V., Moiseenko, F. V., Volkov, N. M., Molchanov, M. S., Ravkina, M. S., Abduloeva, N. Kh, Linets, A. V., Khairutdinov, V. R., Ibragimov, A. M., Moiseyenko, V. M.

“…Aim. Assessment of the utility and advantage of videoendoscopic inguinal femoral lymphadenectomy (VE-LAD) over the standard open technique (OLAD) in patients…”
Get full text

Incidence of Synchronous Multiple Primary Melanoma in Patients with Solitary Melanoma: a Prospective Comparative Study by Egorenkov, V. V., Moiseenko, F. V., Volkov, N. M., Molchanov, M. S., Ravkina, M. S., Abduloeva, N. Kh, Linets, A. V., Khairutdinov, V. R., Aksenov, M. S., Moiseyenko, V. M.

“…Background. Malignant melanoma is steadily exaggerating over the recent decades. Nonetheless, improved systemic therapies have substantially increased life…”
Get full text

Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome by Moiseenko, F.V., Volkov, N.M., Zhabina, A.S., Stepanova, M.L., Rysev, N.A., Klimenko, V.V., Myslik, A.V., Artemieva, E.V., Egorenkov, V.V., Abduloeva, N.H., Ivantsov, A.O., Kuligina, E.S., Imyanitov, E.N., Moiseyenko, V.M.

“…The aim of our trial was to evaluate the prognostic significance of qualitative ctDNA analysis on different stages of EGFR mutated non-small cell lung cancer…”
Get full text

Comprehensive Screening for COVID-19 at St. Petersburg Oncology Centre by Volkov, N. M., Lebedeva, M. S., Egorenkov, V. V., Moiseenko, F. V., Abduloeva, N. Kh, Bogdanov, A. A., Terterov, I. N., Chernobrivceva, V. V., Valeeva, N. E., Myasnikova, E. B., Navatskaya, A. S., Bogdanov, A. A., Moiseyenko, V. M.

“…Background. Clinical reports on the coronavirus disease 2019 (COVID-19) suggest its higher incidence and worse outcomes in cancer patients. Considering a rapid…”
Get full text

Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer by Fedyanin, M. Yu, Moiseenko, F. V., Chekini, D. A., Chubenko, V. A., Zhabina, A. S., Zagorskaya, L. A., Kramchaninov, M. M., Tjulandin, S. A., Moiseyenko, V. M.

“…Introduction. Trifluridine/Tipiracil (FTD/TPI) is a new chemotherapeutic drug approved in more than 60 countries for use in patients with metastatic colorectal…”
Get full text

Mineralization of the Peritoneum — a New Target in the Treatment of Peritoneal Carcinomatosis by Gantsev, Sh. Kh, Moiseenko, V. M., Gantsev, K. Sh, Solomenny, S. V., Kzyrgalin, Sh. R., Dokichev, V. A., Moiseenko, F. V., Minigazimov, R. S.

“…Introduction. This article presents data on the manifestations of changes in the microenvironment of the peritoneal cavity in patients with carcinomatosis,…”
Get full text

Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer by Semiglazova, T. Yu, Lubennikova, E. V., Bolotina, L. V., Orlova, R. V., Moiseenko, F. V., Avramenko, A. V., Artemeva, E. V., Borozdina, S. A., Vakhitova, A. A., Volkov, N. M., Ganshina, I. P., Dzhalilova, Sh. A., Zhukova, L. G., Kasparov, B. S., Kachmazov, A. A., Klimenko, V. V., Kornietskaya, A. I., Meshcheryakov, A. A., Paichadze, A. A., Poltoratsky, A. N., Ryabishina, O. E., Stepanova, M. L., Imyanitov, E. N

“…Introduction. The presence of a germinal BRCA mutation occurs in 3–4% of all breast cancer (BC) patients with various biological subtypes, but significantly…”
Get full text

Molecular genetic studies of glial tumors in children by Soltan, P. S., Moiseenko, F. V., Ochkolyas, V. N., Startsev, V. Yu

“…Glioblastomas are the most frequent malignant neoplasm among primary brain tumors of childhood. Despite the advances in a multimodality treatment approach…”
Get full text

Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer by Frolova, M A, Kochetkova, Ya I, Chubenko, V A, Volkov, N M, Moiseenko, F V, Garmarnik, T V, Ponomarenko, D M, Orlov, A E, Kostalanova, Yu V, Makarycheva, Yu Yu, Nizegorodzeva, A A

“…The article represents case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone…”
Get full text

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study by Pokataev, I. A., Lyadova, M. A., Fedyanin, M. Yu, Tryakin, A. A., Chubenko, V. F., Moiseenko, F. V., Zagorskaya, L. A., Stepanova, M. L., Androsova, A. V., Nosov, D. A., Karpova, N. V., Kit, O. I., Vladimirova, L. Yu, Popova, I. L., Belonogov, A. V., Ponomarenko, D. M., Yukalchuk, D. Yu, Shikina, V. E., Ivanova, N. V., Khasanova, A. I., Kruglov, A. D., Stradaeva, I. Yu, Perepletova, A. S., Filippova, V. M., Buzova, N. L., Khavaneva, O. V., Musaeva, Kh. S., Goryainova, A. Yu, Romanchuk, O. V., Tespizhek, I. Sh, Tyulyandin, S. A.

“…Introduction. The randomized MPACT study showed that nab-paclitaxel plus gemcitabine results in statistically significantly longer life expectancy. The…”
Get full text

Effect of silver oxide nanoparticles on tumor growth in vivo by Rutberg, F. G., Dubina, M. V., Kolikov, V. A., Moiseenko, F. V., Ignat’eva, E. V., Volkov, N. M., Snetov, V. N., Stogov, A. Yu

“…A study investigated the antitumor properties of aqueous dispersions of silver oxide nanoparticles in experiments with rats with Pliss lymphosarcoma…”
Get full text

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study by M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin

“…Objective: to compare the efficacy and tolerability of second‑line chemotherapy with original bevacizumab (Avastin) and biosimilar bevacizumab produced by…”
Get full text

Efficacy and toxicity of aflibercept and bevacizumab in combination with FOLFIRI in second‑line therapy for metastatic colon cancer: a retrospective multicenter study by M.   Yu. Fedyanin, L.  Yu.  Vladimirova, V.  A.  Chubenko, L.   A. Zagorskaya, A.  V.  Belyaeva, O.  L.  Fakhrutdinova, S.  A.  Belukhin, A.   S. Zhabina, L.   V. Khalikova, L.  V.  Bolotina, R.   V. Orlova, F.  V.  Moiseenko, G.   Z. Mukhametshina, A.  I.  Khasanova, A.  V.  Belonogov, Kh.  S.  Musaeva, O.  Yu.  Novikova, I.  Yu.  Stradaeva, I.  L.  Popova, S.  P.  Erdniev, A.  K.  Ivanova, A.  V.  Androsova, P.  S.  Feoktistova, E.  S.  Kuzmina, E.   V. Karabina, O.  V.  Nekrasova, O.  V.  Sekhina, A.   A. Mishchenko, L.  A.  Mukova, B.  Kh.  Kertiev, G.  I.  Kosar, S.   N. Osodoeva, A.  I.  Kats, R.  R.  Malina, M.  A.  Lyadova, A.  A.  Tryakin, S.  A.  Tyulandin

“…Objective: to compare the efficacy and toxicity of aflibercept and bevacizumab in combination with fOLfIRI in secondline therapy for patients with metastatic…”
Get full text

Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer by Fedyanin, M. Yu, Vladimirova, L. Yu, Chubenko, V. A., Zagorskaya, L. A., Belyaeva, A. V., Bolotina, L. V., Moiseenko, F. V., Fakhrutdinova, O. L., Belukhin, S. A., Zhabina, A. S., Khalikova, L. V., Moiseenko, V. M., Meshcheryakov, А. А., Artamonova, E. V., Pokataev, I. A., Khasanova, A. I., Belonogov, A. V., Musaeva, Kh. S., Novikova, O. Yu, Stradaeva, I. Yu, Popova, I. L., Mukhametshina, G. Z., Orlova, R. V., Erdniev, S. P., Ivanova, A. K., Androsova, A. V., Feoktistova, P. S., Kuzmina, E. S., Karabina, E. V., Nekrasova, O. V., Sherstnev, V. M., Mishchenko, A. A., Mukova, L. A., Kertiev, B. Kh, Kosar, G. I., Osodoeva, S. N., Kats, A. I., Malina, R. R., Tryakin, A. A., Tjulandin, S. A.

“…Objective: to identify factors associated with efficacy of an aflibercept-chemotherapy combination in patients with metastatic colon cancer.Materials and…”
Get full text

Long-term outcomes of durvalumab after chemoradiotherapy in locally advanced non-small cell lung cancer in Russia by Yudin, D. I., Laktionov, К. К., Moiseenko, F. V., Ponomarenko, D. M., Сhernykh, M. V., Chubenko, V. A., Levchenko, N. V., Kozlov, V. V., Stepanova, E. О., Khagazheeva, M. N., Yukalchuk, D. Yu

“…Introduction. The results of the PACIFIC trial have changed the standards of care for the patients with unresectable stage III nonsmall cell lung cancer…”
Get full text

First results of durvalumab after chemoradiotherapy in locally advanced non-small-cell lung cancer in Russia by Yudin, D. I., Laktionov, K. K., Moiseenko, F. V., Ponomarenko, D. M., Chekh, E. A., Chubenko, V. A., Levchenko, N. V., Kozlov, V. V., Stepanova, E. О., Sarantseva, K. A., Denisova, E. S., Ardzinba, M. S., Yukalchuk, D. Yu

“…Introduction . The addition of durvalumab after chemoradiation therapy in unresectable stage III non-small-cell lung cancer (NSLC) is a new standard of care…”
Get full text

Personalized therapy in solid tumors: results of a retrospective multicentre study of the clinical applicability of the FoundationOne® Medicine Test by Stepanova, M. L., Kuznetsovа, O. A., Shilo, P. S., Moiseenko, F. V., Abduloeva, N. Kh, Artemyeva, E. V., Zhabina, A. S., Kramchaninov, M. M., Volkov, N. M., Pokataev, I. A., Rumyantsev, A. A., Plaksa, I. L., Gairyan, M. A., Isaev, A. A., Ivanov, M. V., Sadykova, Yu. F., Mileiko, V. A., Shamrikova, V. V., Ledin, E. V., Tryakin, A. A., Fedyanin, M. Yu

“…Background. The use of targeted sequencing panels makes it possible to optimize and personalize the treatment strategy for cancer patients. Given the lack of a…”
Get full text